ANI Pharma (ANIP) Tops Q4 EPS by 8c, Revenues Beat; Offers FY19 EPS/Revenue Outlook
Go back to ANI Pharma (ANIP) Tops Q4 EPS by 8c, Revenues Beat; Offers FY19 EPS/Revenue Outlook| ANI PHARMACEUTICALS (NASDAQ: ANIP) | Delayed: 80.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.58 | 52 Week High | $70.92 | |||
| Open | $80.58 | 52 Week Low | $26.80 | |||
| Day High | $80.58 | P/E | N/A | |||
| Day Low | $80.58 | EPS | $-0.96 | |||
| Volume | 318 | |||||
